Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.
Takei H, Edahiro Y, Mano S, Masubuchi N, Mizukami Y, Imai M, Morishita S, Misawa K, Ochiai T, Tsuneda S, Endo H, Nakamura S, Eto K, Ohsaka A, Araki M, Komatsu N. Takei H, et al. Among authors: masubuchi n. Br J Haematol. 2018 Jun;181(6):791-802. doi: 10.1111/bjh.15266. Epub 2018 May 9. Br J Haematol. 2018. PMID: 29741776 Free article.
A marine sponge-derived lectin reveals hidden pathway for thrombopoietin receptor activation.
Watari H, Kageyama H, Masubuchi N, Nakajima H, Onodera K, Focia PJ, Oshiro T, Matsui T, Kodera Y, Ogawa T, Yokoyama T, Hirayama M, Hori K, Freymann DM, Imai M, Komatsu N, Araki M, Tanaka Y, Sakai R. Watari H, et al. Among authors: masubuchi n. Nat Commun. 2022 Nov 25;13(1):7262. doi: 10.1038/s41467-022-34921-2. Nat Commun. 2022. PMID: 36433967 Free PMC article.
Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics.
Ogama Y, Kumagai Y, Komatsu N, Araki M, Masubuchi N, Akiyoshi H, Matsuura T, Kirisako H, Kyoya A, Nomura F, Ohira Y, Yokokawa T, Yamamoto Y. Ogama Y, et al. Among authors: masubuchi n. Clin Pharmacol Drug Dev. 2023 Jun;12(6):579-587. doi: 10.1002/cpdd.1216. Epub 2022 Dec 30. Clin Pharmacol Drug Dev. 2023. PMID: 36583544 Clinical Trial.
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
Miyagoe-Suzuki Y, Masubuchi N, Miyamoto K, Wada MR, Yuasa S, Saito F, Matsumura K, Kanesaki H, Kudo A, Manya H, Endo T, Takeda S. Miyagoe-Suzuki Y, et al. Among authors: masubuchi n. Mech Dev. 2009 Mar-Apr;126(3-4):107-16. doi: 10.1016/j.mod.2008.12.001. Epub 2008 Dec 16. Mech Dev. 2009. PMID: 19114101 Free article.
36 results